Q4 2022 Brighthouse Financial Inc Earnings Call
Okay.
Welcome to the private house financial.
Good morning, ladies and gentlemen, and welcome to the Brighthouse financial fourth quarter and full year 2022 earnings Conference call. My name is Carmen and I'll be your coordinator for today at this time all participants are in a listen only mode. We will facilitate.
A question and answer session towards the end of the conference call in fairness to all participants please limit yourself to one question and one follow up as a reminder, the conference is being recorded for replay purposes I will now turn the presentation over to Dana 90 head of Investor Relations at Symantec, you'll need.
Proceed.
Thank you Carmen and good morning, welcome to Brighthouse Financial's fourth quarter and full year 2022 earnings call materials for today's call were released last night and can be found on the Investor Relations section of our website. We encourage you to review all of these materials.
Today, you will hear from Eric Steigerwalt, our President and Chief Executive Officer, and Ed Bihar, Our Chief Financial Officer.
Following our prepared remarks, we will open the call up for a question and answer period also here with us today to participate in the discussions are other members of senior management.
Before we begin I'd like to note that our discussion. During this call may include forward looking statements within the meaning of the federal Securities laws.
Bright house Financial's actual results may differ materially from the results anticipated in the forward looking statements as a result of the risks and uncertainties described from time to time in Brighthouse Financial's filings with the U S Securities and Exchange Commission.
Information discussed on today's call speaks only as of today February 10 2023.
The company undertakes no obligation to update any information discussed on today's call.
During this call we will be discussing certain financial measures that are not based on generally accepted accounting principles also known as non-GAAP measures.
Conciliation of these non-GAAP measures on a historical basis to the most directly comparable GAAP measures and related definitions may be found on the Investor relations portion of our website in our earnings release slide presentation and financial supplement.
And finally references to statutory results, including certain statutory based measures used by management are preliminary due to the timing of the filing of the statutory statements.
And now I'll turn the call over to our CEO Eric Steigerwalt.
Thank you Dana and good morning, everyone Brighthouse Financial's fourth quarter results were a strong finish to a successful year in which we maintained a robust capital and liquidity position.
Exceeded our total annuity sales expectations and continued to return capital to our shareholders through our common stock repurchase program.
Before I provide comments on our fourth quarter results I'd like to take a moment to reflect on the year two.
2022 was a difficult year for markets with equity and fixed income indices down significantly amid continued high inflation.
While market performance was a negative for separate account returns our industry benefited from interest rates up over 230 basis points as measured by the 10 year U S Treasury despite.
The challenging environment 2022 marked a year of significant milestones for Brighthouse financial as we continued to execute on our strategy and remain disciplined in our financial and risk management.
As I have said in the past one of our top priorities is balance sheet strength, which we continued to display in 2022.
As we communicated previously and the rising interest rate environment earlier in 2022.
We took the opportunity to add a substantial amount of low interest rate protection.
We took additional actions through year end 2022 to further enhance our interest rate protection in our shift to a more strategic interest rate hedge positioning.
These actions reflect our continued focus on protecting our balance sheet.
Optimizing our distributable earnings.
Supporting the growth of our franchise through a broad range of market scenarios.
We delivered another record year of annuity sales with total annuity sales of $11 5 billion for full year 2022 up 26% compared with 2021.
These strong results demonstrate the strength and complementary nature of our product suite.
And in August of 2022, we launched a new annuity products Brighthouse shield level pay plus expanding our flagship shield level annuity suite.
This product is specifically designed to help meet an important need in retirement planning.
Income that lasts for life.
We are very pleased with the addition of this product to our suite of shield annuities and remain focused on offering a portfolio of products that help meet the evolving needs of clients.
Another significant milestone that we achieved in 2022 was the completion of all our major system conversions. This marks the full implementation of our future state operations and technology platform and the end of establishment costs.
This accomplishment allows us to increase our focus on growth the evolution of our business mix and supporting our distribution franchise.
These strategic and operational milestones have further enhanced the strong franchise that we have built at Brighthouse financial.
Additionally in.
In 2022, we returned capital to our shareholders through the repurchase of $488 million of common stock, which included $93 million of common stock repurchased in the fourth quarter.
As of year end 2022, we have reduced the number of shares outstanding by 43%. Since we began our common stock repurchase program just over four years ago in August of 2018.
I am incredibly proud of all that we achieved in 2022 I would once again like to thank our employees for their hard work and dedication and I would also like to thank our distribution partners for the important role that they play in our success now.
Now moving to fourth quarter results, our balance sheet and liquidity remains strong in the fourth quarter, we estimate our combined risk based capital or RBC ratio was approximately 440% at year end.
This is at the high end of our target RBC ratio range of 400% to 450% in normal markets.
Additionally, we ended the year with $1 billion of holding company liquid assets.
As I mentioned earlier full year 2022 was a record year for annuity sales in the fourth quarter was a strong contributor with total annuity sales of $3 2 billion, an increase of 36% compared with the fourth quarter of 2021.
In the fourth quarter of 2022, we continue to see strong sales of our fixed deferred annuity and shield annuity products as our complementary annuity product suite continues to meet the needs of our distributors and their clients in different market environments.
As we sell the products that we offer today.
For product enhancements and launched new products, while continuing to run off our older less profitable business, we expect our business mix to continue to evolve to a higher cash flow generating and less capital intensive business.
Turning to life insurance in the fourth quarter, we generated $22 million of life insurance sales.
The life insurance sales were down year over year, reflecting the headwinds from the economic backdrop in 2022, we maintained a consistent level of life insurance sales throughout the year.
Importantly, we remain confident in our life insurance strategy.
In 2023, we plan to introduce a new life insurance product, which we expect will further diversify and strengthen our life product suite and we will continue to focus on maintaining and enhancing our suite of life insurance products as well as expanding our distribution footprint into the.
Future.
I am pleased with the results that we delivered in both the full year and the fourth quarter of 2022, we achieved.
The significant strategic and operational milestones and we believe that we are well positioned to continue to execute our focused strategy in 2023.
We continue to prudently manage statutory capital and target a combined RBC ratio as you know of between 400 and 450% in normal markets.
As I mentioned in 2022, we took actions to move toward a more strategic position on interest rate risk and we plan to continue to dynamically adjust our hedge portfolio to evolving market conditions.
Regarding capital return year to date through February seven, we repurchased approximately $27 million of our common stock.
We remain committed to returning capital to shareholders and intend to maintain an active and opportunistic share repurchase program.
However, as we have demonstrated in uncertain market environments, we are focused on protecting our distribution franchise.
To that end, while we continue to repurchase our common stock we have reduced the level of buybacks to reflect a cautious view on both the market and economic environment.
As I also mentioned with the completion of our major system conversions in 2022, we can further increase our focus on growth the evolution of our business mix and supporting our distribution franchise.
To wrap up despite the challenging market environment in 2020 to Brighthouse financial delivered strong results, we maintained a robust capital and liquidity position and we achieved several major strategic and operational milestones.
We're looking forward to 2023 as the Brighthouse financial franchise continues to grow and evolve to a more diversified company.
With that I will turn the call over to Ed to discuss the financial results.
Thank you, Eric and good morning, everyone.
Protecting and supporting our distribution franchise remains a top priority.
And our financial and risk management strategy plays a critical role.
As you've heard me say repeatedly it is our goal to maintain a strong balance sheet under a multi year multi scenario framework.
As our fourth quarter and full year 2022 results demonstrate we maintained a robust capital and liquidity position through the difficult market environment of last year.
At December 31, our combined total adjusted capital or TAC was $8 1 billion <unk>.
Compared with $8 billion at September 30th.
While equity markets were down significantly for the full year.
The market performance in the fourth quarter was positive which contributed to the increase in Tac.
We completed the variable annuity actuarial model conversion in the fourth quarter, along with the annual variable annuity statutory assumption updates.
The combined impact of these two items was relatively modest reducing tact by less than $200 million.
Our combined risk based capital or RBC ratio was approximately 440%, which is near the top end of our target range of 400% to 450% in normal markets.
This ratio was down from an estimated range of 450% to 470% at September 30th.
The sequential decline in the RBC ratio is due to the strong variable annuity or VA results.
Which were more than offset by the impact from the model conversion and actuarial assumption update non.
Non <unk> items and capital used to fund a high level of annuity sales.
The strong new business trends, we saw in the third quarter continued through the end of the year and drove another quarter of above normal capital usage to fund growth.
Growth is essential to drive our business mix toward lower risk higher return products.
And away from legacy variable annuities.
Therefore, we decided to retain capital at Brighthouse life insurance company or blip.
To support excess new business growth.
Rather than fund an ordinary dividend to the holding company in 2022.
We intend to resume dividends from black to the holding company in 2023.
Normalized statutory earnings were approximately $500 million in the fourth quarter.
Which brought full year normalized statutory earnings to approximately $1 billion.
We had a conservative position in the hedge portfolio for equities throughout 2022.
And we benefited from the significant increase in interest rates last year.
Additionally, as Eric mentioned earlier, we took the opportunity in 2022 to add a substantial amount of low interest rate protection and in the fourth quarter extended the duration of that protection.
Moving to the holding company.
We ended the year in a strong position with $1 billion of cash and liquid assets.
In the fourth quarter, New England life insurance company or <unk>.
<unk> paid a $38 million ordinary dividend to the holding company.
Which was more than offset by $93 million of common stock repurchased in the quarter.
As we have said previously the non dividend flows to the holding company cover most of our fixed charges.
And we do not have any debt maturities until 2027.
As a life insurance company, we believe it is appropriate to have a conservative position at the holding company.
Given the uncertain market and macroeconomic environments, we feel very good about our strong position at both the operating companies and the holding company.
Now turning to adjusted earnings results in the fourth quarter.
Adjusted earnings excluding the impact from notable items were $245 million.
Which compares with an adjusted loss on the same basis of $3 million in the third quarter of 2022.
And adjusted earnings of $416 million in the fourth quarter of 2021.
On a combined basis. The notable items in the quarter had a modest impact on our results.
Reducing earnings by only $3 million after tax.
The notable items included.
$839 million unfavorable impact related to actuarial items in the quarter, which included a reinsurance recapture impacting the run off segment.
And refinements of certain actuarial assumptions for the life segment.
Establishment costs of $15 million.
As Eric mentioned, the fourth quarter was the last quarter of establishment costs as we have completed all major systems conversions.
And a $51 million favorable impact related to the resolution of prior year tax matters.
Excluding the impact of these notable items fourth quarter adjusted earnings compared with our quarterly run rate expectation.
Were primarily driven by negative alternative investment performance, partially offset by positive VA separate account performance in the quarter.
The alternative investment performance in the fourth quarter drove lower than expected net investment income of.
Of $86 million or $1 23 per share.
As a reminder, we expect an annual 9% to 11% alternative investment yield over the long term.
In the fourth quarter of 2022, the alternative investment yield was negative 0.2%.
Which was below our quarterly expectation, though higher than the negative yield in the third quarter.
As a result net investment income was higher sequentially driven by the alternative investment returns as well as continued asset growth.
The other major driver of adjusted earnings less notable items when compared with our expected quarterly run rate was.
Was the impact of the positive equity market in the fourth quarter.
Which drove VA separate account returns up six 8%.
This corresponded to actuarial adjustments, which had a favorable impact to earnings of $46 million after tax or <unk> 66 per share above our quarterly expectation.
And as reflected through lower deferred acquisition costs, or DAC amortization and lower reserves in the annuity segment.
Keep in mind the quarter to quarter fluctuation, we see in DAC amortization related to changes in the market will not continue in 2023 and beyond.
Under long duration targeted improvements or L. D Ti, which is the new life insurance industry accounting standard.
Turning to adjusted earnings by segment.
In the fourth quarter, the annuity segment reported adjusted earnings of $286 million.
Sequentially annuity results were driven by the impact of higher VA separate account returns.
Which resulted in lower reserves and lower DAC amortization.
The annuity segment also benefited from higher net investment income sequentially, which was partially offset by lower fees and higher expenses.
The life segment reported an adjusted loss, excluding notable items of $5 million.
On a sequential basis results were driven by higher DAC amortization and higher expenses.
Partially offset by higher net investment income.
The runoff segment, excluding notable items reported an adjusted loss of $96 million.
Sequentially results reflect higher net investment income, partially offset by higher expenses.
Corporate and other reported adjusted earnings excluding notable items of $60 million.
On a sequential basis results were driven by a higher tax benefit and lower expenses.
In closing despite a tough year for the markets, we maintained our balance sheet strength to protect and support our distribution franchise and the customers they serve.
We continue to manage the company using a multi year multi scenario a framework.
And given what we perceived to be an elevated level of uncertainty in markets and the economy, we have been more conservative on capital return recently.
With that we would like to turn the call over to the operator for your questions.
Thank you and as a reminder to ask a question simply press Star one one on your telephone and in the interest of time. Please limit your questions to one and one follow up one moment for our first question. Please.
And it comes from the line of Elyse Greenspan with Wells Fargo. Please go ahead.
Hi, Thanks, Good morning, My first question.
Ed You mentioned that you guys would look to resume dividends from Blake in 2023 do you have a sense of just the timing and the magnitude of dividends that you guys will look to take this year.
Hi, good morning Elyse.
<unk> $300 million for dividends. This year is a good expectation with most of that coming from Blake.
And in terms of timing.
I don't really have anything for you on timing.
Okay. Thanks, and then my second question you guys have a sense.
Earnings emergence thoughts surrounding L. DTI and then are you guys considering.
Adding any additional non-GAAP measures to your disclosures.
Yes.
At this point no.
Yeah.
And then do you have a sense of just how the impact.
The accounting changes would be on your adjusted earnings.
Based on your current disclosures.
Sure at this point I would say.
Pretty modest impact on adjusted earnings from the New accounting standard. So in terms of pieces. There is a portion of fee income in under current accounting that will now go below the line with MRP. So that's a negative but an offset to that will be.
Any.
Death benefit claims and related reserves that are now above the line are also going below the line with MRP.
And then the final piece DAC amortization, while all DAC amortization will now be above the line versus some of it below the line today.
With the new simplified approach to amortization, we don't see a material change in that number relative to what we would expect in a normal quarter under current GAAP and remember there will be no more volatility in the DAC like you saw.
This quarter from markets. So overall adjusted earnings I would expect to be pretty close to what we have today.
In terms of net income I would just first start off by saying as you all know we manage the company for stat.
In cash so we are not managing the company for gap and so I would expect you'll still see volatility associated with the difference between how we manage the company and the GAAP accounting framework. However, I think it has to be an improvement on the net income line versus what we have today.
Because what we have today is it really doesn't work.
If you look at net income for example, our net results for this quarter right. The stock market was strong in the fourth quarter interest rates were up.
So good stuff.
And we lost $1 billion on a net basis.
So clearly current accounting does not capture the fundamental the fundamentals of the business.
Okay.
Thanks for the color.
Thank you one moment for our next question. Please.
And he comes from the line of Tracy <unk> with Barclays. Please proceed.
Thank you Ed.
Can you touch on the reinsurance recapture in the run off segment.
That a life products subject to why RFP treaty, and if so which one and if you could share the net amount at risk or amounting for.
Yes, Hi, Tracy.
Yes.
We're going to keep it a little bit higher level than that.
<unk> had a $39 million unfavorable impact from actuarial items and the biggest piece of that was a $24 million impact from a reinsurance recapture and as you said I believe you said it was in the run off segment.
We've had these from time to time, we get a rate increase from a reinsurer, we evaluate whether it makes sense to accept that or to recapture that business and in this case as has often been the case it made economic sense for us to recapture the business.
Okay.
And part of your playbook to grow fixed annuity sales utilizing reinsurance flow.
Panel pharmacy four charts on cross sale.
Bill.
I imagine this year there'll be greater demand for reinsurance flow by a number of Keybanc can you touch on reinsurance capacity to meet this demand. If there is any deterioration in reinsurance costs, where you may wish to retain more of it that's right.
Hey, Tracy this is David I'll start with that one so we're not going to get into necessarily the structure of our reinsurance agreement.
But <unk>.
2022 was across the industry.
A record year for fixed annuities, and we benefited from that as well and that was partly in conjunction with a reinsurer, we had a competitive offering and strong distribution to sell the products. So we.
We had adequate reinsurance capacity to meet that demand as we think forward into 2023, we're not expecting.
A similar consumer demand to what we saw.
In 2022, but we will continue to assess that demand with in conjunction with our reinsurance partner.
And Tracey just that reinsurer.
Alright, one comment you made I think about the C. Four charge, we have the full C. Four charge on on the fixed annuity premium I think you said a portion of it but we book the full charge.
Oh, no I said penalty.
Of course.
Yes, so that relationship you have.
Do you have that preferred relationship where you.
Would be first in line for capacity in 'twenty three.
I'm not going to get into the structure, but we have a reinsurance relationship with athene for fixed rate annuities.
Alright.
Okay.
Thank you thank.
Thank you one moment for our next question. Please.
And he comes from the line of Ryan Krueger with <unk>. Please proceed.
Hey, Thanks, good morning.
My first question was can you help us think about the.
I guess the level of new business strain.
That you had it I guess that either maybe occurred in the fourth quarter or you would expect on a run rate basis as we move into 'twenty three.
Sure Good morning, Ryan.
For full year, we had a little bit more than 30 points of strain from new business and in the fourth quarter. It was around 10 so.
I would say for the full year strain was high.
Hi, maybe 50% more than what we would see in a typical year.
It's good news because more strained meant more growth and that was our decision to retain capital in black because of the fact that we had this opportunity to.
To produce more sales in the second half of the year than what we had anticipated on the fixed side.
Thanks, and then are you planning to provide updated distributable earnings scenario. Thank.
Thank you have done in the past.
Yes is the short answer I think timing will be different because as we head into this year, we have a lot of work to do on <unk>.
<unk> financial supplement for LD Ti.
Filing an 8-K that will effectively be a recast of our 10-K for LD Ti and in addition, leveraging our new valuation environment.
We completed actuarial transformation in 2022, leveraging that to enhance our D. E projections. So all of that suggests that timing of day disclosure. This year will be closer to mid year versus historically, we've done it in March.
Got it and then if I could sneak in one more I think the statutory mean reversion rate.
I believe it went up 25 basis points at the start of this year.
Well, one is that accurate and then to.
What would be the impact of that on your on your RBC ratio.
Yes. So it did go up and we have seen $200 million to $300 million impact from that.
Last year, the impact was negative $2 50 to 300, so it was on the higher end.
So we will get that benefit in the first quarter. In addition, given where rates are today.
You would be looking at another 50 to 75 basis point increase in the mean reversion point, if you look out $24 25.
Great. Thanks, Ed.
Thank you you're welcome.
One moment for our next question please.
Any.
Alright, I see a question from the line of <unk> Kumar with Jefferies. Please go ahead.
Yes. Thanks.
Can you give us a sense maybe of how your fixed annuity spreads that you are at on new business in the fourth quarter in the third quarter kind of compare to the in force.
Yes, So hey, Sidney this is David.
I'd say given given the rate environment.
With the investment achievable and where credit was the spreads on the product were strong and we were very comfortable with the profitability as well as the competitive nature of the product that we wrote in the quarter.
Got it and then you had made a question you made a comment about.
Not expecting I guess, the same level of fixed annuity sales in 2023.
I guess, where do you see the best growth opportunities in terms of annuities I mean, you mentioned, a new shield product, but just just curious kind of where you think the puck is going on that business.
Hey, good morning, it's Myles I'll take that one so yeah.
We're highly focused on growing shield sales suite of chilled products this year, and that's where we're going to.
We expect to see most of the growth.
Okay. Thanks.
One moment for our next question please.
And it comes from the line of John Barnidge with Piper Sandler. Please proceed.
Thank you very much for the opportunity.
I noticed on the investment portfolio mortgage loan exposure.
Grew from 16% to 20% over the last year can you maybe talk about the attractiveness of that asset class where rates are I get it pairs nicely with spread products I'm curious on that growth through third party investment managers. Thank you.
Yeah, Hi, John It's John .
Yes.
Or more.
Loan portfolio grew from about 16% of our assets to 20% so.
Pretty nice growth during the year.
We like.
As a reminder, it's not just commercial mortgage loans, although they do make up the majority at about $13 5 billion.
We have a $5 billion allocation to residential whole loans and a little over $4 billion in agricultural mortgages.
We like all three of those asset classes for their relative value as well as.
But diversify or away from corporate credit, which is our biggest exposure as you know.
So.
We intended to grow the asset class and you are right.
These loans are really good fit for our institutional spread margin business, which.
Crew by about $5 billion during the year and accounted for a nice portion of the commercial loan growth.
Thank you appreciate the answers.
Thank you one moment for our next question any view to have a question. Please press star one one to get into Q1 moment. Please.
And the question comes from the line of Tom Gallagher with Evercore ISI. Please proceed.
Good morning.
Eric just wanted to start on.
Youre getting a little more cautious on capital return can you just give.
Give some indication about what guidepost you're looking at it.
Is it really just the passage of time.
In terms of the fed tightening cycle, ending and seeing what the impact is.
Before you pivot back to kind of going back to a higher level of capital return any any color on that.
Sure Tom Good morning.
Look I think you've got it but I'm happy to talk for a little bit about it.
We're watching the macroeconomic environment, obviously us and everybody else is watching what the fed is doing.
Are we going to have a real credit cycle or not.
We want to return capital we continue to do so as we speak in the first five weeks, we repurchased about 7% of of our shares.
So it's not like we've stopped returning capital and its definitely strategically not like we're going to start returning capital, but we're cautious we've said this many times you've seen what we've done over the last four years, we want to protect what we've built here, we've got an outstanding distribution franchise.
And I want to make sure that we're in a situation where we can sell.
You saw we were able to pivot last year and I know, we've gotten a couple of questions today with respect to whats going to happen what are you expecting like on fixed annuities.
We're not expecting to sell as much fixed annuities in 'twenty three but we're prepared if the opportunity arises.
So with respect to stock repurchases were watching the fed we're watching to see what kind of credit cycle might happen, but but nothing has changed strategically we want to return capital I hope that helped to some degree Tom.
That does.
My follow up is.
It's really about the competitive conditions and your buffer annuity space and then in the fixed annuity space.
From what I've heard the buffer annuity space has a lot more entrenched.
But whenever I hear that I get worried about price competitiveness and I know, you're one of the founders of that business.
Just curious with a lot more competition coming in are you seeing pricing pressure is it affecting margins or is that still pretty rational and then similar question on the fixed annuity space.
<unk> had two quarters of very strong growth.
I should say strong sales levels.
That's considered among the most commoditized products in the industry and you know the private equity firms with a lot of unique investment strategies are big into that space. So whenever you see sales growth in a space like that it has to make you wonder from my perspective, what's going on and what the margins.
But anyway, sorry for the long winded question.
Yeah, I'll start out I think everybody is going to jump in here Tom.
And you asked a similar question last quarter look ICR reasonable level of discipline, you've heard other companies talk about the fact that.
They are really happy with the returns that they're getting in.
In the fixed space and although you are seeing a lot more competition or.
Or peer companies entering the wireless space generally I see we see decent discipline here I mean, we think this is an excellent product for consumers our distributors love It and we love it as a manufacturer so again I'm using the word generally Tom but generally.
Across.
The the various sales classes are product classes, I'm seeing reasonable discipline, David miles, even add it looks like he wants to jump in Tom you've got alive one here.
Okay.
Alright I'll start.
So I think in addition to what Eric said on the pricing and the economics, we think that simplicity and transparency do matter.
We've continued to enhance our shield suite of products that will continue to keep the product up to day to compete in a variety of market conditions. We're also thinking about ways to address the other consumer needs and we did that.
Successful Lee with shield level pay plus.
Hey, Tom just very quickly so yes, the wireless space is more competitive as you went from three carriers to whatever it is now 20, whatever the number is.
But I would just point out that the returns initially when there were three carriers were very high. So yes. They are lower today, but still attractive just not what they were when they were when you had basically oligopolistic pricing with three players if I look at.
The question you had about competition from alternative asset managers remember, what David said, we have a partnership.
Reinsurance arrangement with Athene, So we are benefiting from that.
That element of the competitive market with the relationship we have.
Yes. So then it's Myles again, I'll kind of wrap this up but to Eric's point. We all are jumping at this question I'm going to focus my comments, specifically on the <unk> category and look I guess as it relates to competition in sales, yes, it's had an impact on sales, but the way we think about.
It's a really positive development for advisors and consumers with more entrants in the space, we like the competitiveness of our product we have a very strong distribution footprint. We remain pleased with our sales and you're seeing us continue to evolve our portfolio of shield products with the new level.
Our new shield level pain, plus product, which gets us into the income category as well.
Hey, Thanks, a lot for the answers guys.
Yes.
Thank you one moment for our next question. Please.
And it comes from the line of Erik bass with Autonomous Research. Please proceed.
Hi, Thank you I was hoping you could provide some more color on corporate expenses this quarter, which it looks like it may have had.
Sort of a positive favorable item in there and then related now established when costs are done how should we think about the expense outlook going forward.
Hey, good morning, Eric So there was favorability in the corporate line.
In in in the fourth quarter.
We tend to call out the biggest items when we put the numbers out the night before because there are always puts and takes so I would say that.
There was favorability in the corporate line. We also had some elevated corporate expenses.
We are impacting other segments. So.
I think if you look at the number that you would calculate from our disclosures of four O nine I think it was $4 nine of.
Earnings ex those items, we identified I would guide you back to the third quarter. When we said I think I said something like run rate looked like $3 60, plus or something.
Obviously, we had buybacks that would have benefited in the fourth quarter relative to that number, but I would I would gravitate more toward.
Toward that end as a kind of go forward number than the than the north of $4 that you would come up with from what we disclosed last night.
I'll take your establishment.
Costs comment Eric.
We're done with establishment costs going forward. So you won't see them anymore, but is there a little hold over into 'twenty. Three is that is that part of what will maybe have or expand our corporate expenses up a little bit in 'twenty three yeah, theres, some clean up stuff as you can.
Imagine you've heard companies like us talk about this for years when when you've got secondary stuff that you got to clean up but generally the future state environment for US is done it's finished and you won't see any more establishment costs. So we did 870 ish of corporate expenses.
2022.
That number will go up a little bit for two reasons, one I already said just some clean up stuff that we'll do in 2023 from a technology point of view and inflation.
Certainly we will be experiencing some inflation employee costs vendor contracts et cetera.
But I'm very pleased with where we are with respect to expenses youre not going to see large scale.
Spence initiative here, though we remain laser focused on expenses every day.
Yeah.
Got it thank you and then Ed.
If you could maybe provide an update on the expected book value impact for al DTI as of year end.
Well I can give you I guess I would reiterate what I said.
Last quarter, because I think it's still stands we gave you that the impacts.
If you look back and then I said, we didn't give you anything as of the third quarter, but I said, given where rates, where we expect it up I can't remember substantial improvement significant whatever word I used.
That still applies as of year end.
Got it thank you.
And just a reminder, I remember we had said that at 12 31 21 that the range was $6 to $8 billion to total equity in three to 4 billion equity ex <unk>. So.
The application of substantial improvement is relative to those numbers.
Got it I appreciate it.
Thank you one moment for our next question. Please.
Okay.
And it comes from the line of Alex Scott with Goldman Sachs. Please proceed.
Hi.
Morning, first one I had is just on the drag of new business.
When I when I look at like overall flows in the organic growth rate.
Yes, it seems like maybe this is.
There is probably a bigger drag.
Not being released on the legacy product.
When do we get to more of a Paris stay where youre deploying capital behind new business in a bigger way, where it's actually a portion to organic growth.
Is that years away is it.
Does that start to unfold.
More medium term, how do we think about that.
Hi, Alex It's Ed So let me see if I can help out a little bit.
If you look at our Tac and our RBC this year right, because I think youre getting too well.
Youre using up it seems a lot of capital to fund growth, where when are you releasing capital from other products I think the numbers this year mask, what's going on a bit here okay.
You look at our TAC It was down from $9 4 billion to $8 1 billion year over year right. So of that $1 3 billion dollar decline I would say $1 2 billion of that would be non.
Non <unk> items, and I would say that.
A good portion of those.
We would expect to reverse over time, so specifically the DTA write down was about $400 million.
We fully expect to utilize our tax attributes over the long term.
Second the MRP impact was 202 hundred $50 million to $300 million negative.
In 2022, and not only is that reversing but as I said you are going in the other direction as we get 25 basis points up in the first quarter of this year and another 50 to 75 basis points in 'twenty four 'twenty five.
And then third we had some <unk> reserves this year that was around $200 million.
And in this instance, I consider those reserves to be equity I don't believe we're going to need them. So I think youre going to see that reverse overtime. So you are talking about a very significant amount of Tac that I don't deem to be really.
Representative of the economics of what's going on at the company.
Putting that into RBC terms right RBC ratio for the year went down from 500.
Two 440.
Of that 60 of that 60 point decline.
Approximately 50 points I would think reverses over time.
The DTA impact is over a longer period of time, the MRP impact is happening now and the <unk>.
TBD.
No.
When you're trying to to get to what actually was going on here at the company.
You add 30 points that was used for growth.
<unk> had about 75 points that I would say it would be non <unk> items and you had about 45 points of core capital generation.
That was very helpful. Thank you.
One I had was just on that system conversion I mean, it seems like as it relates to RBC.
Reasonably good outcome through all of that.
As we think about the next piece of information, that's going to potentially be impacted by the distributable earnings tables.
Do you expect to have much of an impact there I'm just thinking about.
Yes, I mean reversion point, there's obviously a tailwind.
But does that system conversion materially changed to where you project your cash flows into the future.
Yeah, Alex I mean, I don't think theres any material change in how we project but.
We're doing it with we're.
We're doing more in house work with a new projection model and so.
It remains to be seen what the impact will be but whatever the number is I'm going to have more confidence in in the numbers because of the position. We're in now from our actuarial system and projection standpoint, and just to I think there were some questions on this.
Last night, so just to get it out there.
The impact of the systems conversion to VA and the assumption updates was as I said in my prepared remarks less than $200 million. The pieces would be the assumption update component of that was essentially zero.
So you can think about the systems conversion.
Being really what drove the number.
Got it thank you.
Thank you and I have no further questions in queue I will turn the call to Dana Ahmad for final thoughts.
Thank you Carmen and thank you all for joining us today and for your interest in Brighthouse financial I have a great day.
And thank you ladies and gentlemen that concludes today's call. Thank you for participating and you may now disconnect.
The conference will begin shortly to raise and lower Johan during Q&A, you can dial star one one.
[music].
Okay.
Okay.
Okay.
Okay.
Yes.
Okay.
Okay.
Okay.
Okay.
Okay.
Okay.
Okay.